ABSTRACT
Over one-third of the human population is infected with intestinal parasites. In a World Health Organization report (2) , it was observed that 17.3 million deaths, of the global total of 52.2 million deaths, were due to infectious and parasitic diseases. A common nematode parasitic disease of humans is ascariasis, which has a prevalence of 30 -60% in endemic areas, producing symptoms of malnutrition, retardation of growth in children, diarrhea, and abdominal pain and in a smaller proportion of cases, death (3) . Gastrointestinal nematodes are the major cause of morbidity in schoolchildren when measured in disability adjusted life years (DALYs). Levamisole is a representative of an important group of anthelmintic drugs (including pyrantel) that is used for treatment of ascariasis as well as other human nematode parasite infections (4) . Members of this group act rapidly by selectively gating pharmacologically distinctive ionotropic (nicotinic) ACh receptor ion-channels (nAChR) on the body muscles of nematodes (5, 6) .
Human studies show that anthelmintic treatment with cholinergic anthelmintics and other anthelmintics is Ͻ100% effective. Albonico et al. (7) described the efficacy of cholinergic anthelmintics against Ascaris sp. (roundworm), Trichuris sp. (whipworm) and Ancylostoma sp. (hookworm). The cure rates for these parasite species is Ͻ100%. A proportion of parasites is innately resistant and unaffected by treatment. The regular use of anthelmintics produces a Darwinian selection pressure that increases the proportion of resistant individuals in the population (acquired resistance). This has been well established for nematode parasites of domestic animals. More recently, significant resistance of human parasites to cholinergic anthelmintics has been described making the drugs ineffective (8, 9) . The prospect for the development of new anthelmintics is very limited, so there is an urgent need to investigate the mechanisms of anthelmintic resistance and to find new ways to counter resistance.
We have focused on sites of action of the cholinergic anthelmintics to gain a better understanding of their modes of action and mechanisms of resistance. In contraction assays using muscle strips from the parasitic nematode Ascaris suum, we have observed that there are pharmacologically distinct nAChRs that can be activated by the different cholinergic anthelmintics (1) . We were able to separate three types of nAChR: the Nsubtype that is preferentially activated by nicotine; the L-subtype that is preferentially activated by levamisole and antagonized by paraherquamide; and the B-subtype that is preferentially activated by bephenium and antagonized by paraherquamide and 2-desoxoparaherquamide. Our studies also found that levamisole resistance is associated with a loss of sensitivity of the L-subtype receptors with no loss in the sensitivity of the N-subtype of receptors (10, 11) . These observations suggest that N-type and B-type selective cholinergic agonists may be useful for overcoming some types of levamisole resistance.
In addition to the muscle contraction assays, we have also compared the effects of nicotine and levamisole under patch clamp (12) to test our hypothesis that the selectivity of these two ligands is different. We found that both nicotine-and levamisole-activated channels had a wide and overlapping conductance range but that nicotine preferentially activates smaller, 26 pS, channels and that levamisole preferentially activates another, 39 pS, group of channels. In this study, we are able to separate out a third subtype to compare the effects of levamisole and bephenium at the singlechannel level and test the effects of the novel competitive-antagonists paraherquamide and 2-desoxoparaherquamide (13, 14, 15) . We were thereby able to identify the single-channel properties of the N-, L-, and B-receptors. These observations are notable because they emphasize the different selectivity of the different cholinergic anthelmintics between the different subtypes of cholinergic receptor. This means, for example, that loss of the L-subtype with levamisole resistance (15, 11) might be overcome by using other cholinergic agonists (methyridine: N-subtype) or antagonists (2-desoxoparaherquamide; B-subtype) with selectivity for other subtypes of nAChR.
MATERIALS AND METHODS

Maintenance of Ascaris suum
Adult Ascaris suum were collected from the IBP Meat Packing Plant (Storm Lake, IA). The worms were maintained at 32°C in Locke's solution (changed daily) for no longer than 5 days. Locke's solution contains (mM): NaCl, 155; KCl, 5; CaCl 2 , 2; NaHCO 3 , 1.5; d-glucose, 5. Mature, active Ascaris suum ϳ10 -20 cm in length were selected for experiments.
Vesicle Preparation
The muscle membrane vesicle preparation has been described previously (5) and is briefly outlined here. The Ascaris were dissected and a muscle flap was prepared and pinned cuticle side down onto a plastic dish lined with Sylgard. The muscle flap preparation was washed with maintenance solution to remove fragments of the gut. The maintenance solution was then replaced with collagenase solution. After collagenase treatment for 4 -8 min at 37°C, the muscle preparation was washed and incubated at 37°C. Small membranous vesicles, 10 -50 m in diameter, grew out from the membrane of the muscle cells. These membranous vesicles were transferred to a recording chamber.
Electrophysiology
The maintenance solution in the chamber was replaced with bath solution containing (mM): CsCl, 35; Cs acetate, 105; MgCl 2 , 2; HEPES, 10; EGTA, 1; pH 7.2 with CsOH, at room temperature. The vesicle preparation was used within 3 h.
The patch-clamp technique was used to record the singlechannel currents activated by levamisole or bephenium from the vesicle preparation. The pipettes were filled with pipette solution that contained (mM): CsCl, 140; MgCl 2 , 2; HEPES, 10; EGTA, 1; pH 7.2 with CsOH. Pipettes with resistances of 3-5 M⍀ were used. The current signal was amplified by an Axopatch 200B amplifier (Axon Instruments, Union City, CA) filtered at 2 kHz (3-pole Bessel) and then sampled at 25 kHz digitized with a Digidata 1320A (Axon Instruments) and stored on a computer hard disk.
Data analysis
Data were idealized and analyzed using pCLAMP Ver 8.2 software (Axon Instruments). The generally low level of channel opening produced extremely rare multiple opening events; these were omitted from calculations of Popen and mean open time. The current amplitude histograms were fitted with the sum of one, two, and three Gaussian equation to determine the mean current amplitudes of the channel openings. The best Gaussian fits (confidence levelϾ0.95) were used to help determine the number of amplitude populations present in one patch. This analysis and curve fitting were done using pCLAMP 8.2 and Prism V4 (GraphPad Software, San Diego, CA). To fit the distribution of the all the individual levamisole channel conductance, we used a simplex method to minimize the residual sum of squares with the aid of the NAG subroutine E040CCF to fit the sum of three Gaussian distributions (15) and were able to obtain estimates of the areas, mean conductance, and sd of the three populations.
We measured Popen as the patch-Popen (the proportion of time channels in the patch were open during the recording). Results are mean Ϯ se and were tested for normality. Although the distribution of open times were exponential, we found that the distributions of the means of open times from different patches did not deviate significantly from normality so differences between three groups of means was tested by ANOVA and differences between two means were evaluated using t test.
Drugs
Paraherquamide and 2-desoxoparaherquamide were obtained from Pfizer Animal Health (Kalamazoo, MI). Other drugs and chemicals were purchased from Sigma Chemical Co (St. Louis, MO). Paraherquamide or 2-desoxoparaherquamide, dissolved in dimethyl sulfoxide (DMSO), was added to the bath solution to give final concentrations of 0.3-10 M. The concentration of DMSO in bath was always Ͻ0.3%. Levamisole/bephenium were present and in the pipette solution to activate the channels.
RESULTS
Levamisole activated conductance of three different channels
When levamisole (30 M) was used as the agonist in the pipette solution, single-channel currents (Fig. 1A) with a conductance of 18 -53 pS and mean open times of 0.2 -2 ms were observed at membrane potentials of Ϯ75 and Ϯ50 mV from inside-out patches. These channels were never recorded in the absence of levamisole. To confirm that these single-channel currents were indeed activated by levamisole, a series of alternating patch recordings was made from the same "active" vesicle: first with, and then without, levamisole present in the pipette solution. In six such paired recordings, channels were recorded in the presence of levamisole but not in the absence of levamisole. On four occasions, a third patch recording was made from the same "active" vesicle with pipette solution again containing levamisole. Under these conditions, characteristic singlechannel currents were observed in all four of four patches. These observations confirmed that the currents were activated by levamisole.
In each patch, levamisole activated up to three populations of channel currents that were clearly separated by differences in their conductance. Figure 1A shows some representative channel openings at ϩ75 mV in a single patch recording and the amplitude histogram that was fitted by the sum of three Gaussian distributions with mean currents of 2.0, 2.7, and 3.6 pA.
In all experiments where three or more voltages were tested between ϩ75 mV and Ϫ75mV, it was found that the current-voltage relationships of the channels were linear. In some experiments where only two potentials were available, it was also taken that the relationship was linear. We determined conductance from the slopes of the current-voltage plots using linear regression. In Fig. 1B , the channels had a conductance of 26, 36, and 48 pS.
We recorded levamisole-activated currents from 58 such channels from 38 patches: 22 had only 1 conductance level present, 12 had 2 conductance levels present, and 4 had 3 conductance levels present. The conductance ranged from 18 to 53 pS. The wide range of conductance values coupled with the low error associated with the measurement of individual channel conductance (seՅ3 pS, r 2 Ͼ0.95 with currents measured at 3 or more potentials) made it unlikely that there was only a single population of channels present. Since the experimental conditions were equal over an individual patch, the presence of the three types of conductance in single patches revealed the presence of separate and distinctive small-, intermediate-, and largeconductance channel populations. To determine the conductance ranges of the three populations, we determined the mean and 95% confidence intervals of the small, intermediate and large conductance populations from the 4 patches showing the three types of conductance ( Table 1 ). The confidence limits for the small, 22 Next, we classified the remaining channel conductance in the other single or double channel patches into three populations according to their conductance using the 95% confidence intervals determined in the three channel patches. Channels classified as small all had a conductance of Ͻ26.5 pS; channels classified as intermediate had a conductance of 26.5-36.6 pS; and channels classified as large had a conductance of Ͼ38.9 pS. Only two types of conductance that had values between 36.6 and 38.9 could not be classified and were excluded in the following analysis. Table 1 shows that the mean Ϯ se of the conductance for all the small channels was 23 Ϯ 1 pS (nϭ15), and for convenience we refer to this channel as G 25 . The mean Ϯ se of the conductance for all the intermediate channels was 33 Ϯ 1 pS (nϭ22), and we refer to this channel population as G 35 . The mean Ϯ se of the conductance for all the large channels was 45 Ϯ 1 pS (nϭ19), and we refer to this channel as G 45 .
Levamisole preferentially activates G 35 channels
The confidence interval method showed that levamisole preferentially activated G 35 channels over the other subtypes: 27% of the channels were G 25 (15 of 56), 39% were G 35 (22 of 56), and 34% were G 45 (19 of 56) . To estimate the proportion of each subtype present using another approach, we fitted the conductance histogram of all 58 channels activated by levamisole to the sum of three Gaussian distributions using the individual 58 conductance values and an iterative simplex method (58; Fig. 2A) ; 28% of these channels were G 25 channels with a mean Ϯ sd of 24.5 Ϯ 4.3 pS; 58% of the channels were G 35 with a mean Ϯ sd of 36.7 Ϯ 5.3 pS; and 14% were G 45 with a mean Ϯ sd of 49.9 Ϯ 1.6 pS. Both analytical approaches separated the channel subtypes and showed that levamisole activates more G 35 channels than the other receptor channel subtypes. The average conductance of the G 35 channels is close to channels identified as the L-subtype of receptor and the conductance of the G 25 channels is the same as N-subtype of nAChRs (12) .
Bephenium activates only G 35 and G 45 channels
When levamisole in the pipette solution was replaced by 1 or 10 M bephenium (a cholinomimetic anthelmintic), only two channel types, G 35 and G 45 , were observed in the patches. Bephenium did not activate the G 25 channels. In 7 of the 19 patches with 1 M bephenium in the pipette, G 35 and G 45 were recorded simultaneously; in the other patches (12 in 19 patches), only the G 35 or G 45 channel was present. The conductance range of all these channels was from 31 to 49 pS. Using the same approach that we used for the levamisole-activated channel currents, we again evaluated the mean conductance and 95% confidence intervals for the G 35 and G 45 channels. From the two channel recordings in the seven patches, we found that the G 35 channel had a 95% confidence interval of 31.6 -40.2 pS and the G 45 channel had a 95% confidence interval of 41.6 -47.1 pS. We used this information to sort the conductance of the single channel patches: conductance Ͻ40.2 pS was classified as G 35 channels; channels greater than 41.6 pS was classified as G 45 conductance channels. Overall we found that the G 35 channels activated by bephenium had a conductance of 36 Ϯ 1 pS (meanϮse; nϭ10). We found that the conductance of the G 45 activated by bephenium had a conductance of 43 Ϯ 1 pS (meanϮse; nϭ16). The means and the conductance ranges of these two bephenium-activated populations are similar to those of the G 35 and G 45 channels activated by levamisole.
Bephenium activates more G 45 than G 35 channels
The confidence interval method revealed that when 1 M bephenium was the agonist 38% of the channel population was G 35 (10 of 26) and 62% was G 45 (16 of 26) . When the agonist was 10 M bephenium, the proportion of G 35 channels was 42% (8 of 19) and the proportion of G 45 channels was 58% (11 of 19). Thus bephenium activated more G 45 channels than G 35 channels, suggesting that these channels represent the B-subtype of receptors (1).
Different subtypes have different mean open times
Once we had separated the channels activated by 30 M levamisole into G 24 G 35 , and G 45 , we were able to determine their mean open times by fitting a single exponential distribution to events Ͼ0.5 ms. We set the patch potential to ϩ75 mV for these observations to minimize open channel block. In multiple conduc- ANOVA was used to test the difference between the three (G 25 G 35 , G 45 ) groups and significance was found (Fϭ8.9, df 2, PϽ0.005). A t test was used to test the differences between the means of the G 25 and G 35 groups (PϽ0.03), the means of the G 35 , and G 45 (PϽ0.03), and the means of the G 25 and G 45 groups (PϽ0.001): they were all significant (Fig. 3C) .
A similar difference between the G 35 and G 45 channels was observed when bephenium was the agonist, Fig  3B. The mean open times of the G 35 channels activated by 1 M bephenium was 1.1 Ϯ 0.2 ms (meanϮse; nϭ7), and this was significantly (PϽ0.05) shorter than the mean open time of the G 45 population that was 2.4 Ϯ 0.2 ms (meanϮse; nϭ11) when tested with a t test, Fig. 3C . The differences between the mean open times of the different conductance populations are consistent with these channel populations belonging to separable distinctive subtypes groups and not being a single continuum.
Bath application of paraherquamide inhibits the opening of nAChRs
Our earlier muscle contraction experiments have demonstrated that paraherquamide is a competitive antagonist (1). It is not possible to make outside-out patch recordings from the Ascaris muscle vesicles because they are under internal pressure and burst when wholecell recordings are attempted. Fortunately, paraherquamide is lipid soluble and passes from the bath through inside-out patches to reach the extracellular receptor to act as an antagonist (Fig. 4A) . This is a technique that we have established and used for the application of lipid soluble ligands (16, 12) . Here we measured and normalized the antagonism using paired patches. We recorded from two patches and measured the Popen values using the same protocol and time course to control for any rundown or effects of adding solution to the inner membrane. In the first control inside-out patch with channels activated by 30 M levamisole in the pipette, we tested the effect of adding antagonistfree solution to the bath; there was sometimes a small decrease in Popen in the control patch. In the second test patch, with channels also activated by 30 M levamisole in the pipette, we observed the effect on channel opening of adding paraherquamide to the bath. As a normalized measure of inhibition, the percent change in Popen produced by paraherquamide was divided by the percent change in Popen produced by the antagonist-free solution.
The inhibitory effect of paraherquamide was dose dependent (Fig. 4B) and was described by the logistic function with an IC 50 of 3.1 M. Thus, we established that paraherquamide produced a dose-dependent antagonism of levamisole-activated channels. Figure 5A and B, left, shows the representative effects of paraherquamide on channel conductance. It illustrates results from a patch at ϩ75mM with three channels (G 25 pipette before (Fig 5A) and after (Fig 5B) the addition of 1M paraherquamide to the bath. The figure shows that the mean amplitude of each of the channels with a conductance of 27 pS, 37 pS, and 47 pS is the same before and after the addition of paraherquamide. Interestingly, Fig. 5 also shows that although the amplitude of each of the three channels is unchanged by paraherquamide, the overall frequency of the events is reduced due to the inhibitory action of paraherquamide. In all patch recordings, we found no effect of paraherquamide on the amplitudes of any of the channel subtypes. Figure 5A and B, right, illustrates representative effects of 1 M paraherquamide (Fig. 5A, control; Fig.  5B, paraherquamide) Figure 5C shows the effect of 1 M paraherquamide on the three nAChR populations (G 25 , G 35 , and G 45 ) observed in seven patches at ϩ75mV when activated by 30 M levamisole. When 1 M paraherquamide was present in the bath, ANOVA showed that the opening of the three channel populations was inhibited by different amounts (Fϭ6.9, dfϭ2, Pϭ0.01). Figure 5C shows that 1 M paraherquamide had no effect on the G 25 
Paraherquamide has no inhibitory effect on channel conductance or mean open times
DISCUSSION
N-, L-, and B-subtypes identified at the single-channel level on body muscle
We have observed in a muscle strip contraction assays of Ascaris suum (1) that the cholinergic anthelmintics activate three subtypes of receptors on body muscle and that paraherquamide and 2-desoxyparaherquamide are competitive antagonists. There is the N-subtype that is preferentially activated by nicotine but not paraherquamide and 2-deoxyparaherquamide; there is the L-subtype that is preferentially activated by levamisole and antagonized by paraherquamide; and there is the B-subtype that is preferentially activated by bephenium and antagonized by paraherquamide as well as 2-desoxoparaherquamide (1).
In a previous study (13) at the single channel level, comparison of the effects of nicotine and levamisole revealed that nicotine and levamisole could activate a wide range of conductance but that nicotine preferentially activated small 26 pS channels and that levamisole preferentially activated larger channels with a conductance averaging 39 pS. In this current study, we have been able dissect out the third, G 45 , subtype at the single channel level (Fig. 6) . Also in this study we found that levamisole activated channels over a wide conductance range and that in some patches we could identify 3 separate channels that we refer to as G 25 , G 35 , and G 45 with mean conductance around 25, 35, and 45pS respectively. Levamisole activated more G 35 channels than the other two subtypes. Paraherquamide had no effect on the G 25 channels but antagonized the G 35 and G 45 channels in a manner that was consistent with the G 25 channels being the N-subtype not the L-or B-subtype (1).
When we used bephenium as the agonist, it did not activate the G 25 channels but activated more G 45 channels than G 35 channels; furthermore, 2-desoxoparaherquamide selectively inhibited the G 45 channels. We found that 2-desoxoparaherquamide is a more potent antagonist of the G 45 channels than the G 35 pS channels and that 1 M bephenium preferentially activated the G 45 channels. These observations allowed us to identify and confirm that the G 45 channel is the B-subtype and that the L-subtype is the G 35 channel. 2-Desoxoparaherquamide is a more potent antagonist of the B-subtype than of the L-subtype (1) .
In addition to separation of the subtypes by pharmacology and conductance, we found that there were 
Recognition of separate nAChR subtypes in parasitic nematodes is therapeutically significant
We have observed that L-subtype channels decrease in frequency on the body muscle of the nematode parasite Oesphagostomum dentatum (15) and that levamisole resistant isolates of Oesophagostomum dentatum become less sensitive to levamisole (more selective for L-subtype channels) but that they remain sensitive to the Nsubtype agonist methyridine (10) . If levamisole resistance is due to the loss of the L-subtype of receptors, a useful therapeutic approach may be to use cholinergic agonists or antagonists that have selective effects against N-and B-subtypes to treat levamisole resistance. This suggests that 2-desoxoparaherquamide or, a combination of methyridine or oxantel (N-subtype selective) and bephenium may be useful for the treatment of some types of levamisole resistance.
Heterogeneity of nematode nAChRs
We have observed three separate subtypes in the parasitic nematode Ascaris suum, but what is the molecular basis of the heterogeneity? Much information on the structure and function of nematode AChRs has advanced with the study of C. elegans, a soil nematode that has been subjected to detailed genetic analysis. We are encouraged to use C. elegans as a model for the levamisole receptor of parasitic nematodes by molecular phylogenetic analysis (18) . C. elegans belongs to clade V as do many nematode parasites like O. dentatum, and there are strong similarities between the single-channel properties of levamisole receptors of A. suum (clade III) and O. dentatum (clade V; ref 19) . In both nematodes, channel conductance subtypes between 20 -50 pS are observed with conductance subtypes that include the G 25 , G 35 , and G 45. In O. dentatum, however, we were able to separate a fourth G 40 conductance subtype.
With the completion of the C. elegans genome project, the full size of the nematode AChR gene family was finally revealed. There are now a total of 27 AChR subunit genes which is bigger than in mammals (13 genes, and is the largest number of AChR subunit genes in a single species (19) . Homology has allowed these 27 subunits to be divided into five groups named: DEG-3-like; ACR-16-like; ACR-8-like; UNC-38-like; and UNC-29-like. The UNC-29-like subunits are non-␣ subunits, and the remainders are mostly ␣ subunits. If all combinations of ␣ and non-␣ subunit were capable of forming functional AChRs, there could be over 25 (5) or 14,348,907 receptor subtypes, but this is not likely. The molecular structures of levamisole UNC-38 subunit homologues in the parasitic nematodes, Trichostrongylus colubriformis (20) and Hemonchus contortus (21) , are ϳ90% identical to C. elegans, suggesting that information derived from the model nematode may be a useful guide for parasitic nematodes. With a large number of AChR subunits in C. elegans, it is not surprising that we also see heterogeneity in our experiments on parasitic nematodes.
We can see the molecular potential for the heterogeneity, but what is the functional benefit of this extensive heterogeneity? If nematodes are like vertebrates, then the physiological reasons for the heterogeneity include a necessity to have varying sensitivities to the agonist ACh, to vary desensitization, calcium permeability, and distributions in different cells (22) . We know that expression of UNC-38, UNC-29, UNC-63, LEV-1, ACR-8, ACR 16, and ACR-13 (ϭLEV-8) GFP- tagged protein subunits occurs in body muscle cells of C. elegans (23, 24, 25, 26, 27) , but details of the stoichiometric arrangements of the subunits and total number of receptor subtypes remain to be determined. In our study, we demonstrate the presence of three subtypes of AChR in muscle of parasitic nematodes, each with a different sensitivity to cholinergic anthelmintics. The identification of multiple receptor subtypes in parasites has several practical implications. Firstly, it may help understanding of how resistance to the cholinergic anthelmintics can arise: changes in the relative of proportion of each subtype (by up-or down-regulation) will alter the sensitivity of the parasite to a specific anthelmintic. Secondly, therapeutics may benefit: using combinations of compounds that activate all receptor subtypes could enhance cure rates. Finally, it is predicted that, in some instances, parasites resistant to one type of cholinomimetic will retain sensitivity to others (e.g., levamisole resistant parasites can remain sensitive to bephenium or methyridine), thus offering an alternative strategy to deal with resistance. 
SPECIFIC AIMS
Previous contraction studies on the parasitic nematode Ascaris suum demonstrated that cholinergic anthelmintics can activate three (N-, L-, and B-) subtypes of receptors in muscle and that the L-subtype decreases with resistance to levamisole, a cholinergic anthelmintic. We examined the action of levamisole under patch clamp to determine if the three receptor channels could be separated and characterized pharmacologically.
Principle Findings
Levamisole activates three channels with a different conductance in body muscle of Ascaris
When levamisole (30 M) was used as the agonist in the pipette solution, single-channel currents with a conductance of 18 -53 pS and mean open times of 0.2-2.0 ms were observed in Ascaris body muscle. In each patch, levamisole activated up to three populations of channel currents that were clearly separated by differences in their conductance. Figure 1 illustrates examples of the small, intermediate, and large channel currents that were observed at ϩ 75 mV in a single patch recording.
In all experiments where three or more voltages could be tested between ϩ 75 mV and Ϫ75mV, it was found that the current-voltage relationships of the channels were linear; therefore, conductance was determined by linear regression. In Fig. 1B , the channels had a conductance of 26 pS, 36 pS, and 48 pS.
We recorded levamisole-activated currents from 58 channels in 38 patches: 4 patches showed the 3 channels in the same patch. To determine the conductance ranges of the three populations, we determined the 95% confidence intervals of the small, intermediate, and large conductance populations from the four patches with the three channels. The confidence limits obtained from the four patches for the small channels were 17.8 and 26.3 pS; the limits for the intermediate channels were 26.5 and 38.9 pS; the limits for the large channels were 36.6 and 49.3 pS. For convenience, we refer to the small channel as G 25 , the intermediate channel as G 35 , and the large channel as G 45 . We used the confidence intervals to sort channels into the G 25 , G 35 , and G 45 groups to determine their abundance: two channels with a conductance between 36.6 and 38.9 pS could not be assigned to a specific group and were excluded from further analysis.
Levamisole preferentially activated G 35 channels
After sorting this way, we found that levamisole activated more G 35 channels than the other subtypes: 27% of the channels were G 25 , 39% were G 35 , and 34% were G 45 . To estimate the proportion of each subtype present using another approach, we fitted the conductance histogram of all the channels activated by levamisole to the sum of three Gaussian distributions. Both analytical approaches separated three channel subtypes and showed that levamisole activated more G 35 channels than the other receptor channel subtypes.
Bephenium activates only G 35 and G 45 channels
When levamisole in the pipette solution was replaced by 1 or 10 M bephenium (another cholinomimetic anthelmintic), only two channel types, G 35 and G 45 , were observed in the patches. Bephenium did not activate the G 25 channels. Using the same approach that we used for the levamisole-activated channel currents, we evaluated the 95% confidence intervals for the 26 G 35 and G 45 channels recorded from 19 patches. We found that the G 35 channel had a 95% confidence interval of 31.6 -40.2 pS and the G 45 channel had a 95% confidence interval of 41.6 -47.1 pS. The means and the conductance ranges of the two bephenium-activated populations were comparable to those of the G 35 and G 45 channels activated by levamisole.
Bephenium activated more G 45 than G 35 channels
When 1 M bephenium was the agonist, 38% of the channel population was G 35 . Thus, bephenium activated more G 45 channels than G 35 channels, suggesting that these channels represent the B-subtype of receptors.
Different subtypes have different mean open times
With levamisole as the agonist, the G 25 
Bath application of paraherquamide inhibits the opening of nAChRs in inside-out patches
Our earlier muscle contraction experiments have demonstrated that paraherquamide is a competitive antagonists. Since paraherquamide passes through membranes, we were able to measure the antagonism and used paired recordings of the patch-Popen to control for effects of solution change. The inhibitory effect of paraherquamide was dose dependent and described by the logistic function with an IC 50 of 3.1 M. We found 
Inhibitory effects of paraherquamide and 2-desoxoparaherquamide depends on the receptor subtype
We tested the inhibitory effects of 1 M paraherquamide and 3 M 2-desoxoparaherquamide on the Popen of the G 25 , G 35 , and G 45 channels (Fig. 2) . Paraherquamide had no effect on the G 25 population but had a significant inhibitory effect on the G 35 and G 45 channels. The bigger effect on G 35 and G 45 channels is consistent with these channels belonging to the L-and B-subtypes because paraherquamide is a more potent antagonist of these two subtypes than the N-subtype in contraction studies. We also used 10 M bephenium to activate the G 35 and G 45 channels without activating the G 25 channels. 2-Desoxoparaherquamide had a significantly greater inhibitory effect on the G 45 population than the G 35 population, an effect consistent with the G 45 channels being the B-subtype and the G 35 channels being the L-subtype.
CONCLUSIONS AND SIGNIFICANCE
1.6 Billion people throughout the world carry ascariasis and hookworm infections. Approximately one-third of the world's population is suffering from the effects of intestinal nematode parasites, causing low growth-rates in infants, ill-thrift, diarrhea, and in 2% of cases, loss of life. Levamisole and related drugs (pyrantel and oxantel) are particularly desirable for medication, because they have a rapid therapeutic effect within 2 h of administration. Consequently, these drugs are frequently used to combat human intestinal nematode parasites. The continued use of all anthelmintics, including levamisole, is expected to increase the level of resistance. Cure rates are often Ͻ100% and resistance of human parasites to pyrantel has been described previously. Because development of novel anthelmintics is very limited, it is important to understand details of modes of action of existing anthelmintics to determine methods of enhancing their efficacy and to develop approaches that will counter resistance. We have focused on levamisole and related drugs.
Comparison of levamisole and bephenium activated channel currents under patch-clamp separated N-(G 25 ), L-(G 35 ), and B-(G 45 ) subtypes in A. suum with different pharmacological sensitivities and channel conductance and mean open times (Fig. 3) . Before we began our work on the novel antibiotic anthelmintic paraherquamide, its action at the single-channel level was not known. We described how paraherquamide, and the 2-desoxy derivative, separate N-, L-, and Bsubtypes and have different selectivity. The findings of this study will inform the approach for treatment (for increasing efficacy and for managing drug resistance) of a significant human and animal health problems. For example it may be better to combine some of the cholinergic anthelmintics (pyrantel: L-subtype and oxantel: B-subtype) to increase the spectrum of action and to counter resistance. Future therapeutic use and resistance studies of cholinergic anthelmintics should take into account the heterogeneous nature of the nAChR population in parasitic nematodes and the different selectivity of the cholinergic anthelmintics. 
